Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “multiple sclerosis”
Sponsor: Assistance Publique Hopitaux De Marseille
Multiple Sclerosis · Neuromyelitis Optica Spectrum Disorders · Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) · Alzheimer Disease
France
- Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple SclerosisActive Not Recruiting
Sponsor: Sanofi
Multiple Sclerosis
United States, Bulgaria, Canada, Czechia, France +5 more
Sponsor: University Hospital, Montpellier
Relapsing Remitting Multiple Sclerosis · Progressive Multiple Sclerosis · Controls · Multiple Sclerosis
France
- Hybrid Rehabilitation Approach Through Group Exercise and Telerehabilitation in Patients With Multiple SclerosisActive Not Recruiting
Sponsor: Brno University Hospital
Multiple Sclerosis
Czechia
Sponsor: Hope Biosciences Research Foundation
Multiple Sclerosis
United States
Sponsor: Ege University
Multiple Sclerosis · Multiple Sclerosis (MS) - Relapsing-remitting · Fatigue in Multiple Sclerosis · Sexual Disfunction
Turkey (Türkiye)
Sponsor: I.R.C.C.S. Fondazione Santa Lucia
Deglutition Disorders · Multiple Sclerosis
Italy
- Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative DiseasesRecruiting
Sponsor: Novabio Therapeutics
Amyotrophic Lateral Sclerosis (ALS)
China
Sponsor: Sanofi
Multiple Sclerosis
China
Sponsor: Cionic, Inc.
Multiple Sclerosis · Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Chronic Progressive
United States
Sponsor: University Hospital, Clermont-Ferrand
Central Neurogical Impairment
France
- ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research ProgramActive Not Recruiting
Sponsor: The Hospital for Sick Children
Pediatric Multiple Sclerosis
United States, Canada
- Study of Excretion Balance and Pharmacokinetics of [14C]-SAR442168 in Healthy Male SubjectsCompleted
Sponsor: Sanofi
Multiple Sclerosis
United Kingdom
Sponsor: The Hospital for Sick Children
Multiple Sclerosis (MS)
Canada
- Validity and Reliability of the L Test in Single and Dual Task Conditions in Multiple SclerosisCompleted
Sponsor: Sanko University
Multiple Sclerosis · Walking · Validity During Daily Activities
Turkey (Türkiye)
- TANDem-2: Closing the Gap to Interventions for TANDEnrolling By Invitation
Sponsor: Vrije Universiteit Brussel
Adult Caregivers of Individuals With TSC · Tuberous Sclerosis Complex (TSC)
United States, Australia
- Role of Microglia in the Pathogenesis of Progressive Multiple SclerosisActive Not Recruiting
Sponsor: Turku University Hospital
Multiple Sclerosis
Finland
Sponsor: Hopital Nord Franche-Comte
Botulinum Toxin Injection · Stiff Knee Gait · Fall Risk · Rectus Femoris Muscle
France
- Does Microglial Activation Promote Lesion Growth and Progression Among Multiple Sclerosis PatientsEnrolling By Invitation
Sponsor: Turku University Hospital
Multiple Sclerosis
Finland
Sponsor: Charite University, Berlin, Germany
Neurogenic Bladder Dysfunction
Germany
- Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)Enrolling By Invitation
Sponsor: Skripuletz, Thomas Prof. Dr.
Multiple Sclerosis · Clinically Isolated Syndrome (CIS)
Germany
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States
Sponsor: UGECAM Rhône-Alpes
Upper Motor Neuron Disease
France
Sponsor: University of Cadiz
Multiple Sclerosis
Spain
Sponsor: University of Edinburgh
Dementia · Motor Neuron Disease · Multiple Sclerosis · Parkinson Disease
United Kingdom